Chronic Inflammatory Demyelinating Polyneuropathy: How Insights From Disease Biology Inform Novel Therapies
Listen now
Description
Did you know that more than 20% of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) do not respond to current first-line treatments?
Credit available for this activity expires: 5/30/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000839?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them?
Credit available for this activity expires: 06/28/25
Earn Credit / Learning Objectives & Disclosures:...
Published 06/28/24
Published 06/28/24
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice?
Credit available for this activity expires: 6/27/25
Earn Credit / Learning Objectives & Disclosures:...
Published 06/27/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
